LOS ANGELES, February 17, 2015 /PRNewswire/ --
Crossing Rivers Health is utilizing the CompuMed, Inc. (OTCPink:
CMPD) Enterprise Telemedicine Solution for Rural Healthcare to
improve clinical care and lower the cost of healthcare delivery
within its clinics and hospitals.
(Logo:
http://photos.prnewswire.com/prnh/20140721/697628 )
The CompuMed solution provides real-time access to its network
of Board-Certified specialists for interpretations of diagnostic
studies and critical care consulting, as well as world-class,
telemedicine-enabled medical devices.
"CompuMed's Enterprise Telemedicine Solution for Rural
Healthcare enables Crossing Rivers to deliver on our mission of
meeting the health and wellness needs of our communities. We
particularly like the quality and timeliness of the reports we
receive from CompuMed's team of Board-Certified specialists.
Furthermore, their specialists and 24/7 customer support team is
dependable and available when we need them most," said Tim Clark, Crossing Rivers Health, Director of
Medical Imaging.
"We are proud to collaborate with Crossing Rivers Health, one of
the premier Critical Access Hospitals within the U.S. We take the
responsibility of delivering top patient care seriously and are
thrilled by the benefits Crossing Rivers is receiving from CompuMed
in this area," said W. Scott
Rombach, CompuMed's President and CEO.
Details of CompuMed's Enterprise Solution for Rural Healthcare
can be viewed at compumedinc.com.
About CompuMed, Inc.
CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions
provide patients with the highest level of clinical care at reduced
costs. Its telecardiology and teleradiology offerings provide
real-time access to U.S. Board-Certified specialists through
cloud-based technology and integrated medical devices to medical
facilities anywhere in the world. The company has been in business
over 26 years and services over 1,000 clinical settings. CompuMed
is headquartered in Los Angeles,
CA. Visit CompuMed at www.compumedinc.com.
Forward-Looking Statements
Statements contained in this report, such as statements about
revenue, operations, and earnings growth and other financial
results are forward-looking statements pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
All such forward-looking statements including statements concerning
the company's plans, objectives, expectations and intentions are
based largely on management's expectations and are subject to and
qualified by risks and uncertainties that could cause actual
results to differ materially from those expressed or implied by
such statements. These statements are subject to uncertainties and
risks including, without limitation, product and service demand and
acceptance, changes in technology, ability to raise capital, the
availability of appropriate acquisition candidates and/or business
partnerships, economic conditions, the impact of competition and
pricing, capacity and supply constraints or difficulties,
government regulation and other risks identified in the company's
filings with the Securities and Exchange Commission and OTC Pink
operated by OTCMarkets. All such forward-looking statements are
expressly qualified by these cautionary statements. The company
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any forward-looking statements
to reflect events, conditions or circumstances on which any such
statement is based after the date hereof, except as required by
law.
CompuMed, Inc.
Investor Relations
investorrelations@compumed.net
(310) 258-5000 x117
SOURCE CompuMed
